Imperial Tobacco Canada Warns Health Canada on E-cigarette Additives

Jun.14.2024
Imperial Tobacco Canada Warns Health Canada on E-cigarette Additives
Imperial Tobacco Canada warns Health Canada about dangerous ingredients in permitted e-cigarette additives, as outlined in revised tobacco laws.

According to a report by The Malaysian Reserve on June 14th, Imperial Tobacco Canada (ITCAN) has once again warned Health Canada that permitted additives in e-cigarette products contain dangerous ingredients. Detailed information about these ingredients is included in the revised Tobacco and Vaping Products Act (Flavors) Schedules 2 and 3.


The company's Vice President, Eric Gagnon, stated that...


We have submitted a proposal to the Canadian Health Department and have explicitly expressed our concerns about the approved list of additives at the meeting. However, we are worried that our warnings have not been taken seriously. To be blunt, the list contains at least one known substance that may be carcinogenic.


The company emphasized that the list of permitted additives in Health Canada's flavor ban proposal includes some substances that the company and its parent company, British American Tobacco (BAT), do not use at all. They stated that the Canadian government's list of permitted tobacco additives includes ingredients that have been proven and classified as CMR substances, which is essentially encouraging small producers with limited scientific literacy to use inherently unsafe substances in products designed for inhalation into the lungs.


Ganion pointed out that,


One example is isovalerone. This substance has been classified as a carcinogen by the EU and has acute toxicity. It is also banned in Canada's food and drug regulations for use in human cosmetics. However, if the proposed regulations are passed, it could be used in e-cigarette products. This list could potentially turn e-cigarette products with comparatively low health risks into products that are very harmful to consumers.


ITCAN suggests conducting further research on the ingredients list of the proposed recommendations.


We encourage the Canadian Department of Health to reconsider its list and consult with experts to determine the best approach for progress. We are evolving and our primary focus is on reducing the impact of our business on health by introducing alternative products with minimal health implications. The Canadian Department of Health should also do the same, as these regulations have not improved the health status of the Canadian public.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Launches ZYN Nicotine Pouches in Guatemala, Marking First Entry in Central America
PMI Launches ZYN Nicotine Pouches in Guatemala, Marking First Entry in Central America
Philip Morris International (PMI) has launched ZYN nicotine pouches in Guatemala, offering a lower-risk alternative to smoking and accelerating progress toward a smoke-free future. Developed by a Swedish company, the product reduces the emission of harmful chemicals and is targeted at adult smokers.
Jul.07 by 2FIRSTS.ai
BAT: Accelerating Smokeless Transition, with MENA as a Global Strategic Focus
BAT: Accelerating Smokeless Transition, with MENA as a Global Strategic Focus
British American Tobacco accelerates transformation towards smoke-free future in MENA region, playing crucial role in harm reduction.
Jun.11 by 2FIRSTS.ai
Nicotine Pouch Billboards Surge in Minnesota as High School Usage Tops 5%
Nicotine Pouch Billboards Surge in Minnesota as High School Usage Tops 5%
Twenty-seven years after tobacco billboards vanished from Minnesota, ads for nicotine pouches are now proliferating across the state. These products bypass tobacco advertising bans as they contain tobacco-derived nicotine but no tobacco leaf. Their growing appeal among teens—paired with rising usage rates and potential health risks—has alarmed lawmakers and health experts, despite industry claims that pouches aid smoking cessation.
Jul.15 by 2FIRSTS.ai
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.
Jun.26
Pakistan Court Halts E-cigarette Ban, Orders Reopening of Shops
Pakistan Court Halts E-cigarette Ban, Orders Reopening of Shops
After Punjab's blanket ban on vaping, over 70 shop owners petitioned the Lahore High Court and secured provisional relief. The court suspended enforcement actions pending a July 3 hearing, initiating judicial scrutiny of the ban's legal foundations.
Jun.30 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai